Store
World Market for Biomarkers
Publication Date: July 23, 2019
Tags: Cardiovascular Disease, Diagnostic Instruments, Immunoassay, Infectious Diseases, Neurological Diseases, Oncology and Cancer
Pages: 265
SKU: 19-044
Biomarkers are biological or biochemical molecules, genetic changes, or other measurable characteristics that indicate or predict a condition, risk, or likely biological response. They have a wide range of diagnostic applications, including predicting disease risk, diagnosis, prognosis, identifying appropriate therapy, and monitoring disease or its recurrence.
Kalorama Information’s World Market for Biomarkers (Cardiac [cTn, HscTn, Others], Tumor Markers, Infectious Disease Markers, Autoimmune/Allergy Markers, Neurological Markers, C-Reactive Protein and Other Markers) provides an in-depth analysis of the global biomarker market, estimating market sizes from 2014 to 2024, with 2019 as the base year. This report offers market forecasts for the total biomarker market, segmented by application (clinical diagnostic and research biomarkers) and geographical distribution.
Key Features of the Report:
- Market Overview:
- Comprehensive analysis of the biomarker market trends, technological advancements, and key drivers.
- Discussion on the impact of an aging population, targeted therapies, and the clinical diagnostic test market.
- Market Segmentation and Forecasts (2014-2024)
Clinical Diagnostic Biomarker Market by Disease:
- Total Market Growth:
- Analysis of market growth driven by an aging population, new targeted therapies, and the clinical diagnostic test market.
- Key segments such as infectious disease and cancer biomarkers showing varied growth rates.
- Market Data (2014-2024)
Cancer Biomarker Market:
- Cancer Immunoassays:
- Detection of proteins in blood, urine, or other body fluids indicating cancer.
- Use in diagnosis, treatment monitoring, and disease recurrence.
- Market Data (2014-2024)
Infectious Disease Biomarker Market:
- Largest Disease Segment:
- Tests for antigens or nucleic acid sequences, markers of the body’s response, and antibiotic resistance genes.
- Market Data (2014-2024)
Cardiovascular Disease Biomarker Market:
- Cardiac Biomarkers:
- Substances released during heart damage or stress used to diagnose and monitor cardiovascular disease.
- Market Data (2014-2024)
Immunological Disease Biomarker Market:
- Autoimmune and Allergy:
- Diagnostic testing for autoimmune diseases and allergic responses.
- Market Data (2014-2024)
Neurological Disease Biomarker Market:
- Central and Peripheral Nervous System Disorders:
- Age-related diseases, neurodegenerative diseases, and autoimmune diseases.
- Market Data (2014-2024)
Other Diseases:
- Broad Definition of Biomarkers:
- Used for a variety of diagnostic applications across different disease types.
- Market Data (2014-2024)
C-Reactive Protein (CRP):
- High-Interest Biomarker:
- Detailed sales breakout of CRP tests.
- Market Data (2014-2024)
Market Drivers and Restraints:
- Applications Focus:
- Research and diagnostic applications of biomarkers.
- Analysis of market drivers and restraints at macro and segment levels.
Key Technologies and Companies:
- Technologies Used:
- Traditional and new technologies for biomarker discovery, detection, and analysis.
- Selected Companies:
- Profiles of key players using various technologies and commercializing biomarker tests.
Competitive Landscape:
- Company Profiles:
- Detailed profiles of companies active in biomarker discovery and commercialization.
- Focus on companies with commercialized products and advanced development programs.
Table: Total Global Biomarker Market, by Application, 2014-2024 (in millions $)
| Year | Clinical Diagnostic | Research | Total |
| 2014 | $XX Million | $XX Million | $XX Million |
| 2015 | $XX Million | $XX Million | $XX Million |
| 2016 | $XX Million | $XX Million | $XX Million |
| 2017 | $XX Million | $XX Million | $XX Million |
| 2018 | $XX Million | $XX Million | $XX Million |
| 2019 | $XX Million | $XX Million | $XX Million |
| 2020 | $XX Million | $XX Million | $XX Million |
| 2021 | $XX Million | $XX Million | $XX Million |
| 2022 | $XX Million | $XX Million | $XX Million |
| 2023 | $XX Million | $XX Million | $XX Million |
| 2024 | $XX Million | $XX Million | $XX Million |
| CAGR 2014-2019 | $XX Million | $XX Million | $XX Million |
| CAGR 2019-2024 | $XX Million | $XX Million | $XX Million |
| CAGR 2014-2024 | $XX Million | $XX Million | $XX Million |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
Overview
Scope and Methodology
Market Summary
- Exhibit 1-1: Total Global Biomarker Market, 2014 ñ 2024, in $Millions
- Exhibit 1-2: Growth of Total Global Biomarker Market, 2014 ñ 2024, in $Millions
Chapter 2: Introduction
Overview
- What Are Biomarkers?
- Why Biomarkers Are Important
- Biomarker Validation
- Exhibit 2-1: FDA-Qualified Biomarkers, 2019
Chapter 3: Key Technologies Used to Identify & Analyze Biomarkers
Overview
Immunoassays
- Key Players
- Exhibit 3-1: Selected Companies Using Immunoassays for Detection and Analysis of Biomarkers, 2019
Immunohistochemistry (IHC)
- Key Players
- Exhibit 3-2: Selected Companies with Immunohistochemistry Tests for Detection of Biomarkers, 2019
Flow Cytometry
- Key Players
In Situ Hybridization
- Key Players
- Exhibit 3-3: Selected Companies Using In Situ Hybridization for Detection and Analysis of Biomarkers, 2019
Nucleic Acid Amplification Technologies
- Key Players
- Exhibit 3-4: Selected Companies Using PCR or Other Nucleic Acid Amplification-Based Technologies for Biomarker Assays, 2019
Pharmacogenomics
- Exhibit 3-5: Pharmacogenomic Biomarkers in Drug Labeling, 2019
Gene Signatures
- Key Players
- Exhibit 3-6: Selected Companies Analyzing Gene Signatures, 2019
Microarrays
- Key Players
- Protein Microarrays
- Exhibit 3-7: Selected Companies Using Microarrays to Detect and Analyze Biomarkers, 2019
- DNA Microarrays
- Chromosomal Microarrays
- Tissue Microarrays
Sequencing Technologies
- Key Players
- Exhibit 3-8: Selected Diagnostics Companies and Clinical Laboratories with Sequencing-Based Biomarkers, 2019
- Sanger Sequencing
- Early Next Generation Sequencing Technologies
- Sequencing by Synthesis (SBS)
- Supported Oligonucleotide Ligation and Detection (SOLiD)
- Ion Torrent Sequencing
Mass Spectrometry
- Research and Clinical Applications of Mass Spectrometry
- Key Players
- Exhibit 3-9: Selected Companies Using Mass Spectrometry, 2019
Non-Invasive Prenatal Testing
Liquid Biopsies ñ Circulating Tumor Cells and Circulating Tumor DNA (Cell Free DNA)
Digital Pathology and Image Cytometry
Information Technology
Chapter 4: Cancer Biomarkers
Overview
-
- Exhibit 4-1: Widely Used Tumor Markers, 2019
Assessing Risk of Cancer
- Key Players
- Exhibit 4-2: Selected Biomarkers and Biomarker Panels to Assess Risk of Cancer and Companies Marketing These Biomarkers, 2019
Cancer Screening
- Key Players
- Exhibit 4-3: Selected Biomarkers and Biomarker Panels for Cancer Screening and Companies Marketing These Biomarkers, 2019
Diagnosis and Monitoring of Cancer
- Key Players
- Exhibit 4-4: Selected Biomarkers and Biomarker Panels for Diagnosis and/or Monitoring of Cancer and Companies Marketing These Biomarkers, 2019
Predicting Prognosis
- Key Players
Personalized Medicine/Precision Testing- Key Players
- Exhibit 4-5: Selected FDA Cleared/Approved Companion Diagnostic Tests and Companies Marketing These Biomarkers, 2019
- Key Players
Chapter 5: Cardiovascular Disease Biomarkers
Overview
Acute Myocardial Infarction and Acute Coronary Syndrome Biomarkers
- Key Players
Heart Failure Biomarkers- Exhibit 5-1: Selected Biomarkers and Biomarker Panels for Cardiovascular Disease and Companies Marketing These Biomarkers, 2019
Lipid Disorder Biomarkers
- Key Players
- Exhibit 5-2: Selected Lipid Biomarkers and Companies Marketing These Biomarkers, 2019
Chapter 6: Immunological Disease Biomarkers
Overview
- Key Players
Autoimmune Disease Biomarkers
Inflammation/Inflammatory Disease Biomarkers
Other Immune-Related Disease Biomarkers
- Exhibit 6-1: Selected Biomarkers for Immunological Disorders and Companies Marketing These Biomarkers, 2019
Chapter 7: Infectious Disease Biomarkers
Overview
Infectious Disease Biomarkers
- Key Players
- Exhibit 7-1: Selected Biomarkers for Infectious Disease and Companies Marketing These Biomarkers, 2019
Antibiotic Resistance Biomarkers
- Key Players
- Exhibit 7-2: Selected Biomarkers and Other Tests for Antibiotic Resistance and Companies Marketing These Biomarkers, 2019
Sepsis Biomarkers
- Key Players
- Exhibit 7-3: Selected Biomarkers for Sepsis and Companies Marketing These Biomarkers, 2019
Chapter 8: Neurological Disease Biomarkers
Overview
- Key Players
Alzheimerís Disease Biomarkers
Other Neurological Disorder Biomarkers
- Exhibit 8-1: Selected Biomarkers for Neurological Disorders and Companies Marketing These Biomarkers, 2019
Chapter 9: Global Biomarker Market Forecasts
Overview
Total Biomarker Market
Biomarker Market by Application
- Clinical Diagnostic Biomarker Market
- Research Biomarker Market
- Exhibit 9-1: Total Global Biomarker Market by Application, 2014 ñ 2024, in $Millions (Clinical Diagnostic, Research, Total)
- Exhibit 9-2: Growth of Global Biomarker Market by Application, 2014 ñ 2024, in $Millions (Clinical Diagnostic, Research)
- Exhibit 9-3: Biomarker Market Segments by Application, 2014, 2019, 2024, by Share (%) (Clinical Diagnostic, Research)
Biomarker Market Geographical Distribution
- Exhibit 9-4: Total Global Biomarker Market by Region 2014 ñ 2024, in $Millions (North America, European Union, Japan, China, India, ROW, Total)
- Exhibit 9-5: Growth of Global Biomarker Market by Region, 2014 ñ 2024, in $Millions (North America, European Union, Japan, China, India, ROW)
- Exhibit 9-6: Global Market Segments by Region, 2014, 2019, 2024, by Share (%) (North America, European Union, Japan, China, India, ROW)
Clinical Diagnostic Biomarker Market by Disease
- Exhibit 9-7: Total Global Clinical Diagnostic Biomarker Market, 2014 ñ 2024, in $Millions (Cancer, Cardiovascular Disease, Immunological Disease, Infectious Disease, Neurological Disease, Other, Total)
- Exhibit 9-8: Growth of Total Global Clinical Diagnostic Biomarker Market, 2014 ñ 2024, in $Millions (Cancer, Cardiovascular Disease, Immunological Disease, Infectious Disease, Neurological Disease, Other)
- Exhibit 9-9: Clinical Diagnostic Biomarker Market Segments, 2014, 2019, 2024, by Share (Cancer, Cardiovascular Disease, Immunological Disease, Infectious Disease, Neurological Disease, Other)
- Cancer Biomarker Market
- Exhibit 9-10: Total Global Clinical Diagnostic Cancer Biomarker Market, 2014 ñ 2024, in $Millions (Histology/Cytology, Immunoassays, Flow Cytometry, Rapid Tests, Molecular Assays, Total)
- Exhibit 9-11: Growth of Global Clinical Diagnostic Cancer Biomarker Market, 2014 ñ 2024, in $Millions (Cancer, Cardiovascular Disease, Immunological Disease, Infectious Disease, Neurological Disease)
- Exhibit 9-12: Clinical Diagnostic Cancer Biomarker Market Segments, 2014, 2019, 2024, by Share (%) (Cancer, Cardiovascular Disease, Immunological Disease, Infectious Disease, Neurological Disease)
- Exhibit 9-13: Total Global Clinical Diagnostic Cancer Biomarker Market by Segment, 2014, 2019, 2024, in $Millions (Histology/Cytology: Immunohistochemistry, In Situ Hybridization; Immunoassays – Tumor Markers: PSA, CEA, CA 125, AFP, Others, Flow Cytometry; Rapid Tests: Fecal Occult Blood, PSA, NMP22, Others; Molecular Assays; Total)
- Cardiovascular Disease Biomarker Market
- Exhibit 9-14: Total Global Clinical Diagnostic Cardiovascular Disease Biomarker Market, 2014 ñ 2024, in $Millions (Cardiac Markers, Cholesterol/Lipids, Coagulation, Total)
- Exhibit 9-15: Growth of Global Clinical Diagnostic Cardiovascular Disease Biomarker Market, 2014 ñ 2024, in $Millions (Cardiac Markers, Cholesterol/Lipids, Coagulation)
- Exhibit 9-16: Clinical Diagnostic Cardiovascular Disease Biomarker Market Segments, 2014, 2019, 2024, by Share (%) (Cardiac Markers, Cholesterol/Lipids, Coagulation)
- Exhibit 9-17: Total Global Clinical Diagnostic Cardiovascular Disease Biomarker Market by Segment, 2014, 2019, 2024, in $Millions (Cardiac Markers [Acute Condition Cardiac Markers: CK-MB, myoglobin, brain natriuretic peptide (BNP); cTn; HscTn; Other cardiac markers: proBNP, hsCRP, homocysteine, others], Cholesterol/Lipids, Coagulation [PT/INR-lab, D-dimer, Molecular (Thrombophilia SNPs), POC], Total)
- Immunological Disease Biomarker Market
- Exhibit 9-18: Total Global Clinical Diagnostic Immunological Disease Biomarker Market, 2014 ñ 2024, in $Millions (Autoimmune Disease, Allergy, Total)
- Exhibit 9-19: Growth of Global Clinical Diagnostic Immunological Disease Biomarker Market, 2014 ñ 2024, in $Millions (Autoimmune Disease, Allergy)
- Exhibit 9-20: Clinical Diagnostic Immunological Disease Biomarker Market Segments, 2014, 2019, 2024, by Share (%) (Autoimmune Disease, Allergy)
- Infectious Disease Biomarker Market
- Exhibit 9-21: Total Global Clinical Diagnostic Infectious Disease Biomarker Market, 2014 ñ 2024, in $Millions (Cardiac Markers, Cholesterol/Lipids, Coagulation, Total)
- Exhibit 9-22: Growth of Global Clinical Diagnostic Infectious Disease Biomarker Market, 2014 ñ 2024, in $Millions (Laboratory Immunoassays, Rapid Immunoassays, Molecular Assays)
- Exhibit 9-23: Clinical Diagnostic Immunological Disease Biomarker Market Segments, 2014, 2019, 2024, by Share (%) (Laboratory Immunoassays, Rapid Immunoassays, Molecular Assays)
- Exhibit 9-24: Total Global Clinical Diagnostic Infectious Disease Biomarker Market by Segment, 2014, 2019, 2024, in $Millions (Laboratory Immunoassays [Hepatitis; HIV; STDs including chlamydia, gonorrhea and syphilis; TORCH; Respiratory; Sepsis including sepsis markers, C. difficile, MRSA, other AMR/HAI tests; Parasitology; Mycology; Others including EBV, Chagas, dengue, malaria, Lyme disease, others], Rapid Immunoassays [Influenza; HIV; Malaria; Hepatitis; STDs including chlamydia and syphilis; C. difficile; E. coli; Strep A; H. pylori; Others including rapid tests for TB, Dengue, Chagas, vaginitis, Group B Strep and others], Molecular Assays [HAIs; HIV; Hepatitis; Chlamydia/Gonorrhea (CT/NG); HPV; Respiratory; Mycobacteria/TB; Others], Total)
- Neurological Disease Biomarker Market
- Exhibit 9-25: Total Global Clinical Diagnostic Neurological Disease Biomarker Market, 2014 ñ 2024, in $Millions (Autoimmune Disease, Allergy, Total)
- Exhibit 9-26: Growth of Global Clinical Diagnostic Neurological Disease Biomarker Market, 2014 ñ 2024, in $Millions (Alzheimer’s Disease, Other Neurological Disorders)
- Exhibit 9-27: Clinical Diagnostic Neurological Disease Biomarker Market Segments, 2014, 2019, 2024, by Share (%) (Alzheimer’s Disease, Other Neurological Disorders)
- Other Biomarker Markets
- Exhibit 9-28: Total Global Clinical Diagnostic Other Biomarker Market, 2014 ñ 2024, in $Millions (General Clinical Chemistry, Fertility/Pregnancy, Thyroid, Diabetes/Hb1Ac, Chromosome Analysis & Inherited Disease, Other, Total)
- Exhibit 9-29: Growth of Global Clinical Diagnostic Other Biomarker Market, 2014 ñ 2024, in $Millions (General Clinical Chemistry, Fertility/Pregnancy, Thyroid, Diabetes/Hb1Ac, Chromosome Analysis & Inherited Disease, Other)
- Exhibit 9-30: Clinical Diagnostic Other Biomarker Market Segments, 2014, 2019, 2024, by Share (%)(General Clinical Chemistry, Fertility/Pregnancy, Thyroid, Diabetes/Hb1Ac, Chromosome Analysis & Inherited Disease, Other)
- C-Reactive Protein (CRP)
- Exhibit 9-31: Total Global CRP Biomarker Market, 2014 ñ 2024, in $Millions
- Exhibit 9-32: Growth of Global CRP Biomarker Market, 2014 ñ 2024, in $Millions
Chapter 10: Biomarker Market Analysis
Overview
Market Drivers and Restraints
- Market Drivers
- Market Restraints
Chapter 11: Company Profiles
-
- Exhibit 11-1: Selected Players in the Global Biomarker Market, 2019
20/20 GeneSystems, Inc.
Abacus Diagnostica Oy
Abbott Laboratories
Act Genomics Co., Ltd.
Adaptive Biotechnologies Corp.
Admera Health
Agena Bioscience Inc.
Agendia NV
Agilent Technologies, Inc.
ALPCO
Ambry Genetics Corp.
Athena Diagnostics, Inc. /Quest
Banyan Biomarkers, Inc.
Beckman Coulter, Inc./Danaher Corp.
Becton, Dickinson and Company
BioFire Diagnostics, LLC/BioMerieux
Biohit Oyj
bioMÈrieux SA
Bio-Rad Laboratories, Inc.
Cancer Genetics, Inc.
Caris Life Sciences
Cepheid/Danaher Corp.
Curetis AG
Exact Sciences Corp.
Foundation Medicine, Inc.
Fujirebio, Inc.
Genomic Health, Inc.
Hologic, Inc.
Illumina, Inc.
Myriad Genetics
NeoGenomics
Ortho-Clinical Diagnostics
Qiagen N.V.
Roche
Siemens Healthineers
Sysmex Corp.
Thermo Fisher Scientific, Inc.
Ventana Medical Systems, Inc./Roche
Zeus Scientific, Inc.
Related products
In Vitro Diagnostic (IVD) Procedure Volumes, 2023-2028
October 22, 2023
Gain invaluable insights into the global IVD market with Kalorama Information’s comprehensive report In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028. This analysis provides essential data on the number of IVD procedures, offering a gold standard for new entrants and existing marketers in the diagnostic products industry.
…
Price range: $6,000.00 through $9,000.00
Hematology and Coagulation Markets, 2023
April 5, 2023
Discover the lucrative $10 billion-dollar market for hematology and coagulation in vitro diagnostic (IVD) testing with Kalorama’s comprehensive report, Hematology and Coagulation Markets, 2023. This analysis delves into the dynamic growth factors driving this market, including new technologies, the aging population, and the increasing demand for decentralized testing.
Key Insights Provided:
- Market sizing…
Price range: $3,000.00 through $4,500.00
In Vitro Diagnostic (IVD) Trends and Market Update: March 2024
March 26, 2024
Explore the latest trends and developments in the in vitro diagnostic (IVD) market with Kalorama Information’s comprehensive report, In Vitro Diagnostic (IVD) Trends and Market Update: March 2024. Gain insights into key growth segments, industry trends, and emerging technologies shaping the future of IVD.
The report offers updated data analysis based on Kalorama Information’s annual…
Price range: $5,000.00 through $7,875.00
